[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Biotech Pharma Investor posts on X about decent, $qnrx, $aztr, $qure the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance XXXXX%
Social topic influence decent 5.88%, $qnrx 5.88%, $aztr 5.88%, $qure 5.88%, $nuvb 5.88%, $sgmo 5.88%, $capr 5.88%, $evax 5.88%, $jspr 5.88%, $kala XXXX%
Top accounts mentioned or mentioned by @piratewaffle @therealupndown @aaronrosenblum5 @sanctuarybio @healthcareninj1 @biovalues @hall8jack
Top posts by engagements in the last XX hours
"@PirateWaffle It is aimed to be used long term. So black box warning or not it has to be tolerable. Note it will be stat sign vs placebo (not SOC). Needs to have a decent F-VASI50/75 to stand a chance. Also 24weeks is too little. Maybe they have better selected patients in ph2b and do better" @Stmkrs on X 2025-07-24 03:07:29 UTC XXX followers, XX engagements
"@PirateWaffle Graph looks nice. But translates to the photos you see. Obviously better improvement expected at 24w vs 16w. At 16w V-FASI75 in just X patient" @Stmkrs on X 2025-07-24 01:23:40 UTC XXX followers, XXX engagements
"@AaronRosenblum5 @PirateWaffle Diacontinuation at high dose Where is this info When did the company talked down odda of being as good as opz" @Stmkrs on X 2025-07-23 20:34:23 UTC XXX followers, XXX engagements
"@PirateWaffle For patients to make sense to use long term a daily cream it needs a high F-VASI75. Or else the result is what you see in the photo (not meaningful improvement- I would say first patient looks worse with treatment). The reddit tolerabity post was also quite concering" @Stmkrs on X 2025-07-24 01:29:19 UTC XXX followers, XXX engagements
"@PirateWaffle I havent looked for a few months. To my understanding based on the last PR there arent any warrants left rights" @Stmkrs on X 2025-07-23 04:13:24 UTC XXX followers, XX engagements
"@Sanctuary_Bio @HealthcareNinj1 Well there are X deaths after approval. X different product but same adenovirus platform. The question is whether there is convincing enough rationale this a non-ambulatory patients problem only" @Stmkrs on X 2025-07-19 16:08:59 UTC XXX followers, XXX engagements
"@BioValues $VYNE $KALA $JSPR $EVAX $CAPR $SGMO $NUVB $QURE $AZTR $QNRX" @Stmkrs on X 2025-07-13 04:44:52 UTC XX followers, 2013 engagements